Public health guidance on HIV, hepatitis B and C testing in the EU/EEA
This guidance aims to provide EU/EEA countries with an evidence-based framework to help develop, implement, monitor and evaluate their own national HBV, HCV and HIV testing guidelines and programmes.
Rapid risk assessment: Louse-borne relapsing fever in the Netherlands, 27 July 2015
Following reports from the Netherlands of two cases of louse-borne relapsing fever in asylum seekers coming from Eritrea, ECDC has assessed the risk to Europe.
Rapid risk assessment: Cutaneous diphtheria among recently arrived refugees and asylum-seekers in the EU, 31 July 2015
This rapid risk assessment concludes that there is currently no indication that these cases represent a significant outbreak of diphtheria among refugees in Europe.
Risk of importation and spread of malaria and other vector-borne diseases associated with the arrival of migrants to the EU, 22 October 2015
This rapid risk assessment assesses the specific risk related to importation and spread of vector borne diseases in the context of a large number of migrants to the EU. It does not cover other health needs for these populations.
Rapid risk assessment: Shigellosis among refugees in the EU, 30 November 2015
The occurrence of shigellosis among refugees is not unexpected because shigellosis is endemic in the countries they originate from, as well as in some of the countries they travel through.